BAGUISI, ALEXANDER B.,BEEUWKES, REINIER,CASALE, RALPH,KATES, STEVEN A.,LADER, ALAN S.
申请号：
CA2761798
公开号：
CA2761798C
申请日:
2010.05.13
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention relates, in some embodiments, to compositions comprisinga substantially pure compoundrepresented by Structural Formula (I) and methods of using such compounds toactivate cytoprotective kinases. In additional embodiments,the invention relates to methods for treating an ischemia or an ischemia-reperfusion injury in a subject, comprising administeringto the subject an effective amount of a compound of the invention (e.g., inmultiple doses). The values and preferredvalues of the variables in Structural Formula (I) are defined herein.
